Karo Pharma AB Logo

Karo Pharma AB

KARO | ST

Overview

Corporate Details

ISIN(s):
NO0010308240 (+4 more)
LEI:
213800G54Z51LOPGTA79
Country:
Sweden
Address:
BOX 16184, 103 24 STOCKHOLM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Karo Healthcare AB, formerly Karo Pharma AB, is a healthcare company focused on providing consumer products for everyday health. The company owns and commercializes a portfolio of branded over-the-counter (OTC) products and prescription medicines across categories such as skin health, foot health, intimate health, and digestive health. Its mission is to empower individuals to make 'smart choices for everyday healthcare,' helping to prevent illness and treat common health problems. With a strong presence in Europe and the Nordic region, Karo Healthcare's products are available in over 90 countries worldwide.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Karo Pharma AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-05-31 16:00
Post-Annual General Meeting Information
Kommuniké från Karo Pharmas årsstämma 2022
Swedish 1.4 MB
2022-05-27 16:00
Pre-Annual General Meeting Information
Ändringar i Karo Intressenter AB:s förslag avseende val av styrelse till Karo P…
Swedish 1.1 MB
2022-05-02 18:30
Pre-Annual General Meeting Information
KALLELSE TILL ÅRSSTÄMMA I KARO PHARMA AKTIEBOLAG
Swedish 4.9 MB
2022-04-19 08:30
Share Issue/Capital Change
Karo Pharmas företrädesemission fulltecknad
Swedish 3.6 MB
2022-04-19 08:30
Share Issue/Capital Change
Karo Pharma’s rights issue fully subscribed
English 3.6 MB
2022-04-01 13:30
M&A Activity
Karo Pharma slutför förvärvet av E45® från Reckitt
Swedish 21.3 KB
2022-04-01 13:30
M&A Activity
Karo Pharma completes the acquisition of the E45® brand from Reckitt
English 46.1 KB
2022-03-23 12:00
Delisting Announcement
Karo Pharma offentliggör prospekt avseende företrädesemissionen och erhåller go…
Swedish 460.3 KB
2022-03-23 12:00
Report Publication Announcement
Karo Pharma publishes prospectus relating to the rights issue and receives appr…
English 438.3 KB
2022-03-16 08:00
Share Issue/Capital Change
Karo Pharma resolves on a fully guaranteed rights issue of approximately SEK 2.…
English 156.1 KB
2022-03-16 08:00
Share Issue/Capital Change
Karo Pharma beslutar om en fullt garanterad företrädesemission om cirka 2,5 mil…
Swedish 156.3 KB
2022-03-10 14:00
Delisting Announcement
Karo Pharma receives approval to delist the Company’s share from Nasdaq Stockho…
English 697.2 KB
2022-03-10 14:00
Delisting Announcement
Karo Pharma erhåller villkorat godkännande om avnotering av Bolagets aktier frå…
Swedish 696.0 KB
2022-03-09 12:00
Delisting Announcement
Karo Pharma applies for delisting of the Company’s shares from Nasdaq Stockholm…
English 51.0 KB
2022-03-09 12:00
Delisting Announcement
Karo Pharma ansöker om avnotering av Bolagets aktier från Nasdaq Stockholm i sa…
Swedish 51.7 KB

Automate Your Workflow. Get a real-time feed of all Karo Pharma AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Karo Pharma AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Galderma Group AG Logo
A dermatology company providing aesthetic, skincare, and therapeutic solutions worldwide.
Switzerland GALD
Genetic Analysis AS Logo
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
Norway GEAN
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye GENIL
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GlaxoSmithKline PLC Logo
Develops vaccines and specialty medicines for infectious diseases, HIV, oncology, and immunology.
United Kingdom GSK
GNI  Group Ltd. Logo Japan 2160
Gour Medical Logo
Developed veterinary diagnostics and treatments for companion and production animals.
France MLGML
Grifols S.A. Logo
Develops plasma-derived medicines & biopharma solutions for rare and chronic conditions.
Spain GRF
Grindeks Logo
Pharmaceutical company developing and selling original/generic drugs & APIs globally.
Latvia GRD1R